Objective. Thymus alterations have been related to several autoimmune disorders. In particular, previous studies identified a significant frequency of gland abnormalities by chest high-resolution CT (HRCT) in SSc patients. In this study we aimed to investigate the prevalence of radiological thymic alterations and their correlation with clinical and serological features in a large SSc series.
Introduction
SSc is an autoimmune disease characterized by endothelial dysfunction and fibrotic tissue overgrowth involving the skin and visceral organs [1] . The aetiology of SSc remains obscure, but a specific role for immunological abnormalities has been raised [1] .
The thymus, a primary lymphoid organ, plays a crucial role in immune system homeostasis. In fact, development of the functional repertoire of T cells by means of TCR specificity-based selections initiates in the thymus [2] . Autoimmune diseases such as SSc result from a loss of self-tolerance, possibly linked to defects in the thymic epithelial microenvironment [3] , therefore thymic disorders might be potentially involved in the pathogenesis of different immune-mediated disorders [3] , including SSc. In our preliminary report and in a few other studies [46] , this hypothesis has been supported by the observation of thymic morphological alterations at CT evaluation. These findings are in keeping with several anecdotal reports on thymic abnormalities in scleroderma patients [715] . On this basis we further investigated the prevalence of radiological thymic alterations and their correlation with clinical and serological features in a larger SSc series.
Patients and methods
Two hundred consecutive, unselected SSc patients [19 males/181 females, mean age 57.8 years (S.D. 12.8), median disease duration 5 years (range 038)] were evaluated. Written consent was obtained according to the Declaration of Helsinki and the study was approved by the local ethics committee (Comitato Etico Provinciale di Modena, Italy). Subjects <30 years old were excluded in order to eliminate possible physiologically incomplete thymic involution. In addition, the present series did not include any patients considered in our previous study [6] . Patients with SSc fulfilled the ACR classification criteria [16] and were recruited from our tertiary university-based rheumatologic centre. Epidemiological, clinical and serological features are presented in Table 1 .
The presence of thymus alterations was detected by means of high-resolution CT (HRCT) of the chest, which was performed to study SSc interstitial lung disease in our clinical practice. All HRCT scans were re-evaluated for thymic alterations by a trained radiologist. The thymus evaluation was carried out as previously described [6] . Briefly, images of the thymus, reviewed at the mediastinal window, were reconstructed using 3 mm thickness, 1 mm interval and a field of view small enough to include all the gland. Thymus size was measured using the thickness (normal value <13 mm). Moreover, in the case of a focal soft-tissue density, a cut-off of 7 mm was used. Thus CT thymic images were classified into three groups: hyperplasic, nodular, and negative thymus.
Furthermore, CT scans were also reclassified according to the method used by Meunier et al. [5] : in the case of the presence of a gland with thickness <7 mm and/or with fat density only, a complete thymic involution was diagnosed, otherwise an incomplete involution of the thymus was reported. Moreover, according to this method, nodular thymuses were excluded, to exclude possible neoplastic cases. Statistical comparison between patients with normal thymus and those with abnormal thymus showed lower age (P < 0.0001) and higher frequency of diffuse cutaneous subset (P = 0.002) in the second group. Subsequently the latter is divided between patients with thymic hyperplasia (n = 19) and patients with thymic nodules (n = 5). Statistical comparison between these two subgroups showed lower age (P = 0.0006), higher frequency of lung fibrosis (P = 0.041) and lower frequency of renal insufficiency (P = 0.036) in patients with thymic hyperplasia. ANoA: anti-nucleolar antibodies; DL CO : single breath diffusing capacity for carbon monoxide; Paps: pulmonary arterial systolic pressure.
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Statistical analysis was performed by Fisher's exact test or chi-square test and a P-value of < 0.05 was considered significant.
Results
Twenty-four of 200 (12%) SSc patients presented an abnormal thymus at HRCT, i.e. hyperplasic (19/24) or nodular (5/24) glands. Otherwise, using the cut-off of 7 mm and excluding subjects with nodular thymus, 50/195 (25.6%) patients presented an incomplete thymic involution ( Table 1 ). The first 19 cases with hyperplasic thymus are all included in the group of incomplete thymic involution, classified according to the second method of classification [5] . Among these 19 patients we noted a 36-year-old male who underwent a thymectomy; the histopathological evaluation revealed thymic hyperplasia ( Table 2) .
The mean age of SSc patients with abnormal thymus at HRCT was significantly lower compared with patients with normal thymus using both methods of classification (P < 0.001 and P = 0.008, respectively; Tables 1). More interestingly, patients with abnormal thymus tended to have a shorter disease duration at the time of the study (Table 1) . Also, no significant differences were reported if nodular thymuses were excluded from the study. Considering the cut-off of 5 years of disease duration, patients with shorter disease duration more frequently had an abnormal thymus compared with those with a longer clinical history (66.7% vs 33.3%), whereas among subjects with a normal thymus, the number of patients with a disease duration < 5 years was comparable to that of patients with a disease duration of > 5 years (49.4% vs 50.6%).
The correlation between clinical, serological and instrumental features of SSc patients with thymic alterations revealed a significant association with skin involvement; i.e. patients with diffuse cutaneous SSc showed a higher prevalence of thymic alterations, regardless of the radiological evaluation methods used. Following the first radiological classification [6], if we exclude individuals with nodular lesions, SSc patients with thymic hyperplasia (19/200) maintained the above statistical differences.
Discussion
The present study on a large SSc series confirmed the high prevalence of thymic radiological alterations among SSc patients, particularly thymic hyperplasia, previously observed in a small cohort of patients [6] . These alterations are significantly correlated with younger patient age and the diffuse skin SSc subset. Moreover, a higher prevalence of thymic hyperplasia was detected in patients with shorter disease duration.
The actual significance of these radiological alterations is difficult to appropriately explain; in particular, the possible etiopathogenetic role of thymic hyperplasia in this immune-mediated systemic disorder.
The thymus is the lymphoid organ where naive T lymphocytes develop, following a programme of events that involves antigen-presenting cells (APCs) [2] . It is well documented that the deletion of autoreactive T cells is regulated by the strength of the signalling transduced by the interaction between the TCR and the self Since 1962 the association between SSc and thymic hyperplasia or thymoma has been described in several case reports [715] . Histopathological evaluation of the gland was carried out in 18 SSc patients (3 from our case series) who underwent thymectomy or autopsy, demonstrating 5 cases of neoplasia and 6 of hyperplasia, whereas 7 patients showed a normal thymus (Table 2) . These case reports are very heterogeneous with regard to patients' clinical features and data collection, therefore it is extremely difficult to extrapolate clear information.
In 2006 our group presented the first casecontrol study suggesting the possible role of thymic disorders, particularly hyperplasia, in the SSc pathogenesis. The study showed an abnormally enlarged thymus in 15% of cases or nodular thymus in 6% [6] . Of interest, these alterations were never detected in controls, whereas incomplete thymus involution was observed in 26% of SSc patients, with a comparable percentage in healthy controls. In SSc patients, thymus alterations were associated with a shorter disease duration ( < 5 years) and anti-Scl70 positivity. In the present study the latter correlation was not confirmed, while an increased percentage of the diffuse SSc subset emerged.
In 2009 Oksel et al.
[4] evaluated the frequency of radiological thymus abnormalities in 63 female SSc patients and the relationship with various clinical and laboratory features compared with 45 age-matched controls. Patients underwent HRCT and thymus alterations were qualitatively classified as incomplete involution when thymus tissue could be observed as a nodular or linear structure. Incomplete thymus involution was present in 19% of SSc patients (with a frequency significantly higher than the control group), and was more frequently associated with limited SSc. Results showed an inverse relation between thymic alterations and pulmonary fibrosis.
More recently, Meunier et al.
[5] evaluated incomplete thymus involution in SSc and RA patients. Pulmonary CT scan was performed in 96 SSc patients and thymic alterations were classified as incomplete involution if residual thymus tissue measuring >7 mm across the short axis on the axial slice was found, according to Francis et al. [20] . The SSc patients with incomplete thymic involution (14/96, 15%) were younger than the SSc patients with complete thymic involution and were more likely to have a pulmonary restrictive syndrome [assessed by forced vital capacity (FVC%)].
The studies by Oksel et al. [4] and Meunier et al. [5] consistently found that SSc patients with incomplete thymic involution were younger compared with those without, but no correlations with the skin subsets were observed. However, the significant association between the presence of a restrictive pulmonary syndrome [5] or a better alveolar diffusion of carbon monoxide [4] and incomplete thymic involution was not confirmed in our study. These differences may be because of the different method used to define thymic abnormalities or the small number of patients investigated.
In addition to the criteria followed in our preliminary work, we used a second method to identify thymic abnormalities based on the cut-off of 7 mm of thymus thickness, according to Meunier et al. [5] . This second method may be less discriminating and specific compared with the first, which considered a cut-off of 13 mm. As expected, patients with thymic hyperplasia represent a subgroup of those with incomplete thymic involution. However, the analysis of our case series using both radiological methods led to the same significant correlations. Available data from the literature about the physiological dimensions of the thymus are not so robust [21] . As regards HRCT, a study by Baron et al. [22] indicated thymic thickness as an accurate indicator of infiltrative diseases of the thymus (hyperplasia and lymphoma). In a study by Francis et al. [20] , the 11 individuals with normal thymus included in the analysis presented a mean thymic thickness of 0.930.99 cm. On this basis, a cut-off of 7 mm appears to be scarcely specific in the context of a cohort study, even if it may be useful in controlled studies comparing patients versus healthy subjects. Laboratory and histopathological investigations of thymus alterations in SSc patients are very difficult in clinical practice, but the large majority of SSc patients referred to tertiary centres present with overt disease. In this context, advanced scleroderma may hide thymus alterations and possibly may contribute to gland involution. Only multicentre studies could recruit a significant number of individuals with very early phases of the disease when thymicdriven autoimmune phenomena might be decisive for SSc development.
Thymic lymphoid hyperplasia is characterized by the presence of an increased number of B cells and lymphoid follicles with germinal centres [23] . On the other hand, thymuses with lymphofollicular hyperplasia can present weight and volume within the normal range [24] , so that the actual frequency of SSc patients with thymic hyperplasia might be underestimated. Even if B cells are demonstrated to be located in normal thymuses, they are separated from thymic epithelial cells [25] ; otherwise, in lymphofollicular hyperplasia the basal lamina that separates epithelial cells (and T cells) from perivascular spaces containing B cells is frequently disrupted [26] , allowing interactions between the two populations of lymphocytes, possibly leading to a non-tolerogenic www.rheumatology.oxfordjournals.org maturation of T cells. Indeed, T cells play a prominent role in SSc pathogenesis, while the cytokines secreted by these cells (i.e. IL-4, IL-6 and IL-13) are profibrotic [27] . This could be consistent with the correlation found in the present study between the diffuse SSc skin subset and thymic hyperplasia.
In conclusion, a significant percentage of our SSc patients presented with thymic enlargement, suggestive of thymic hyperplasia. These findings are quite suggestive for a possible role of thymus dysfunction in SSc, mainly in the very early, often unnoticeable phases of the disease.
Rheumatology key messages
. Radiological thymic alterations are frequent in SSc. . Thymic abnormalities are more common in younger SSc patients and the diffuse skin subset. . Thymic abnormalities tend to be related to shorter disease duration in SSc.
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